期刊文献+

生长抑素受体亚型介导人肝癌细胞凋亡的实验研究 被引量:2

The apoptosis of human hepatocellular carcinoma cells mediated by somatostatin receptor subtypes
下载PDF
导出
摘要 目的研究生长抑素类似物奥曲肽诱导人肝癌细胞株细胞凋亡的作用,观察不同的人肝癌细胞株生长抑素受体(SSTR)亚型的表达情况。探讨SSTR亚型与肝癌细胞凋亡之间的关系。方法分别培养人肝癌细胞株(SMMC-7721,HHC-98,HepG2),荧光染色、透射电镜和流式细胞仪检测细胞凋亡;RT-PCR检测细胞SSTR亚型mRNA的表达。结果0.25-4.0μg/mL的奥曲肽作用48h后,三种肝癌细胞部分呈现典型的凋亡形态学改变,细胞凋亡率呈浓度依赖性升高。3种肝癌细胞株均表达SSTR2、3、4,SSTR5则在两种肝癌细胞株SMMC-7721和HHC-98中表达,所有细胞株均未检测到SSTR1的表达。结论奥曲肽可以诱导肝癌细胞凋亡,其作用与肝癌细胞中广泛表达的SSTR亚型相关。 Objective To investigate the effect of octreotide on apoptosis of different human hepatocellular carcinoma (HCC) cells and the expression of somatostatin receptor (SSTR) subtypes on HCC cells. Methods Three different kinds of hepatocellular carcinoma cells (HepG2, SMMC-7721 and HHC-98) were cultured in vitro, The apoptosis was detected by fluorescent staining, transmission electron microscope and flow cytometry, and SSTR subtype mRNAs of these cells were determined by reverse transcription polymerase chain reaction. Results With a few of octreotide concentrations (0. 25 μg/mL, 1. 0 μg/mL, 2. 0 μg/mL and 4. 0μg/mL ) were increased, apoptosis was induced by octreotide in HCC cells. SSTR2.3 and 4 were positive in all three hepatocellular carcinoma cells, and SSTR5 was found in SMMC-7721 and HHC-98 cells, no SSTR1 was detected in HCC cells. Conclusion SSTRs are widely expressed in hepatocellular carcinoma cells and the apoptosis induced by octreotide may mediated by SSTRs.
出处 《肿瘤》 CAS CSCD 北大核心 2005年第3期232-235,共4页 Tumor
关键词 肝肿瘤 肝细胞 细胞系 肿瘤 受体 生长抑素 细胞凋亡 Liver neoplasms Carcinma.hepatocellular Cell line,tumer Recepors,somatostatin Apoptosis
  • 相关文献

参考文献14

  • 1霍立,刘海林,王磊.奥曲肽对人肝癌细胞生长增殖、甲胎蛋白合成及细胞凋亡的作用[J].中华消化杂志,2002,22(6):331-334. 被引量:16
  • 2Kouroumalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study[J]. Gut, 1998,42 : 442-447. 被引量:1
  • 3Samonakis DN, Moschandreas J, Arnaoutis T, et al. Treatment of hepatocellular carcinoma with long acting somatostatin analogues[J]. Oncol Rep,2002,9: 903-907. 被引量:1
  • 4Raderer M, Hejna MH, Muller C, et al. Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo[J]. Int J Oncol,2000,16: 1197-1201. 被引量:1
  • 5Chen X, Liu Z, Ai Z. Antineoplastic mechanism of octreotide action in human hepatoma[J]. Chin Med J (Engl) 2001,114:1167-1170. 被引量:1
  • 6Diaconu CC, Szathmari M, Keri G, et al. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232[J]. Br J Cancer, 1999,80 : 1197-1203. 被引量:1
  • 7Nakaizumi A, Uehara H, Baba M, et al. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats [ J ]. Carcinogenesis, 1993, 14:2601-2604. 被引量:1
  • 8Davies N, Yates J, Kynaston H, et al. Effects of octreotide on liver regeneration and tumour growth in the regenerating liver[J]. J Gastroenterol Hepatol, 1997,12: 47-53. 被引量:1
  • 9Schindel DT, Grosfeld JL. Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide[J]. J Pediatr Surg, 1997, 32: 995-998. 被引量:1
  • 10Slooter GD, Breeman WA, Marquet RL, et al. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver[J]. Int J Cancer, 1999,81 : 767-771. 被引量:1

二级参考文献1

共引文献15

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部